CYH - CYH Shareholder News: Johnson Fistel Encourages Community Health Shareholders with Losses to Contact the Firm Regarding Investigation
SAN DIEGO, July 28, 2022 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP ( www.JohnsonFistel.com ) is investigating whether Community Health Systems, Inc. (“Community Health” or the “Company”) (NYSE: CYH ), any of its executive officers, or others violated securities laws by misrepresenting or failing to timely disclose material, adverse information to investors. The investigation focus on investors' losses and whether they may be recovered under the federal securities laws.
What if I purchased Community Health common stock? If you purchased Community Health common stock and suffered significant losses on your investment, join our investigation now:
- Click or paste the following web address into your browser to submit your losses:
https://www.johnsonfistel.com/investigations/community-health-systems-cyh-class-action
Or for more information, contact Jim Baker at jimb@johnsonfistel.com or (619) 814-4471
There is no cost or obligation to you.
What is Johnson Fistel investigating? On July 27, 2022, Community Health reported Q2 non-GAAP EPS of -$2.52, compared to a net income of $0.23 per share a year ago. The company also said it now expects a loss per share for 2022 in the range of $1.65 to $2.55, compared to guidance provided in its Q1 report in April in which it said it expected a net income per share of $0.75 to $1.30. Following this news, Community Health stock was trading down over 35% in early morning trading on July 28, 2022.
What if I have relevant nonpublic information? Individuals with nonpublic information regarding the company should consider whether to assist our investigation or take advantage of the SEC Whistleblower program. Under the SEC program, whistleblowers who provide original information may, under certain circumstances, receive rewards totaling up to thirty percent of any successful recovery made by the SEC. For more information, contact Jim Baker at (619) 814-4471 or jimb@johnsonfistel.com .
Contact:
Johnson Fistel, LLP
Jim Baker, Lead Securities Analyst
Telephone: (619) 814-4471
Email: jimb@johnsonfistel.com